Mammographic microcalcifications and risk of breast cancer.
Journal
British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
12
02
2021
accepted:
02
06
2021
revised:
18
05
2021
pubmed:
16
6
2021
medline:
17
12
2021
entrez:
15
6
2021
Statut:
ppublish
Résumé
Mammographic microcalcifications are considered early signs of breast cancer (BC). We examined the association between microcalcification clusters and the risk of overall and subtype-specific BC. Furthermore, we studied how mammographic density (MD) influences the association between microcalcification clusters and BC risk. We used a prospective cohort (n = 53,273) of Swedish women with comprehensive information on BC risk factors and mammograms. The total number of microcalcification clusters and MD were measured using a computer-aided detection system and the STRATUS method, respectively. Cox regressions and logistic regressions were used to analyse the data. Overall, 676 women were diagnosed with BC. Women with ≥3 microcalcification clusters had a hazard ratio [HR] of 2.17 (95% confidence interval [CI] = 1.57-3.01) compared to women with no clusters. The estimated risk was more pronounced in premenopausal women (HR = 2.93; 95% CI = 1.67-5.16). For postmenopausal women, microcalcification clusters and MD had a similar influence on BC risk. No interaction was observed between microcalcification clusters and MD. Microcalcification clusters were significantly associated with in situ breast cancer (odds ratio: 2.03; 95% CI = 1.13-3.63). Microcalcification clusters are an independent risk factor for BC, with a higher estimated risk in premenopausal women. In postmenopausal women, microcalcification clusters have a similar association with BC as baseline MD.
Sections du résumé
BACKGROUND
Mammographic microcalcifications are considered early signs of breast cancer (BC). We examined the association between microcalcification clusters and the risk of overall and subtype-specific BC. Furthermore, we studied how mammographic density (MD) influences the association between microcalcification clusters and BC risk.
METHODS
We used a prospective cohort (n = 53,273) of Swedish women with comprehensive information on BC risk factors and mammograms. The total number of microcalcification clusters and MD were measured using a computer-aided detection system and the STRATUS method, respectively. Cox regressions and logistic regressions were used to analyse the data.
RESULTS
Overall, 676 women were diagnosed with BC. Women with ≥3 microcalcification clusters had a hazard ratio [HR] of 2.17 (95% confidence interval [CI] = 1.57-3.01) compared to women with no clusters. The estimated risk was more pronounced in premenopausal women (HR = 2.93; 95% CI = 1.67-5.16). For postmenopausal women, microcalcification clusters and MD had a similar influence on BC risk. No interaction was observed between microcalcification clusters and MD. Microcalcification clusters were significantly associated with in situ breast cancer (odds ratio: 2.03; 95% CI = 1.13-3.63).
CONCLUSIONS
Microcalcification clusters are an independent risk factor for BC, with a higher estimated risk in premenopausal women. In postmenopausal women, microcalcification clusters have a similar association with BC as baseline MD.
Identifiants
pubmed: 34127810
doi: 10.1038/s41416-021-01459-x
pii: 10.1038/s41416-021-01459-x
pmc: PMC8405644
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
759-765Informations de copyright
© 2021. The Author(s).
Références
Wilkinson L, Thomas V, Sharma N. Microcalcification on mammography: approaches to interpretation and biopsy. Br J Radiol. 2017;90:20160594.
doi: 10.1259/bjr.20160594
Cox RF, Hernandez-Santana A, Ramdass S, McMahon G, Harmey JH, Morgan MP. Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation. Br J Cancer. 2012;106:525–37.
doi: 10.1038/bjc.2011.583
Henrot P, Leroux A, Barlier C, Genin P. Breast microcalcifications: the lesions in anatomical pathology. Diagnostic Interventional Imaging. 2014;95:141–52.
doi: 10.1016/j.diii.2013.12.011
Park JM, Choi HK, Bae SJ, Lee MS, Ahn SH, Gong G. Clustering of breast microcalcifications: revisited. Clin Radiol. 2000;55:114–8.
doi: 10.1053/crad.1999.0220
Stomper PC, Geradts J, Edge SB, Levine EG. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. AJR Am. J. Roentgenol. 2003;181:1679–84.
doi: 10.2214/ajr.181.6.1811679
Ali MCK, Hall P, Humphreys K. Association of microcalcification clusters with short-term invasive breast cancer risk and breast cancer risk factors. Sci Rep. 2019;9:1–8.
Hofvind S, Iversen BF, Eriksen L, Styr BM, Kjellevold K, Kurz KD. Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening. Acta Radiol. 2011;52:481–7.
doi: 10.1258/ar.2011.100357
Stomper PC, Connolly JL. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. Am J Roentgenol. 1992;159:483–5.
doi: 10.2214/ajr.159.3.1323923
Thomas DB, Whitehead J, Dorse C, Threatt BA, Gilbert FI Jr., Present AJ, et al. Mammographic calcifications and risk of subsequent breast cancer. J Natl Cancer Inst. 1993;85:230–5.
doi: 10.1093/jnci/85.3.230
Castells X, Tora-Rocamora I, Posso M, Roman M, Vernet-Tomas M, Rodriguez-Arana A, et al. Risk of breast cancer in women with false-positive results according to mammographic features. Radiology. 2016;280:379–86.
doi: 10.1148/radiol.2016151174
Eriksson M, Czene K, Pawitan Y, Leifland K, Darabi H, Hall P. A clinical model for identifying the short-term risk of breast cancer. Breast Cancer Res. 2017;19:29.
doi: 10.1186/s13058-017-0820-y
Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–86.
doi: 10.1093/jnci/81.24.1879
Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 2008;98:1457–66.
doi: 10.1038/sj.bjc.6604305
Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, et al. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. 2015;107:djv036. https://doi.org/10.1093/jnci/djv036 .
Darabi H, Czene K, Zhao W, Liu J, Hall P, Humphreys K. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res. 2012;14:R25.
doi: 10.1186/bcr3110
Gabrielson M, Eriksson M, Hammarstrom M, Borgquist S, Leifland K, Czene K, et al. Cohort profile: the Karolinska mammography project for risk prediction of breast cancer (KARMA). Int J Epidemiol. 2017;46:1740–1g.
doi: 10.1093/ije/dyw357
iCAD. Breast health solutions: advanced cancer detection built on artificial intelligence. ProFound AI, 2019-09-27. https://www.icadmed.com/home.html .
Food and Drug Administeration - Summary of Safety and Effectiveness Data Mammoreader -iCAD. U.S Food and drug administeration. Date of Notice of Approval to Applicant: January 15, 2002. https://www.accessdata.fda.gov/cdrh_docs/pdf/P010038b.pdf .
Jeffrey C, Wehnes JP, MonacoDavid S, HardingJames H, PikeAnbinh T, HoLawrence MH. Microcalcification detection classification in radiographic images. United States Patent and Trademark. 2014.
Wehnes JM, J Harding, D Anbinh, P Hanafy, L. Microcalcification detection classification in radiographic images. United States Patent and Trademark. 2014.
Azam S, Eriksson M, Sjölander A, Gabrielson M, Hellgren R, Czene K, et al. Predictors of mammographic microcalcifications. Int J Cancer. 2020;148:1132–43.
Shao Y-Z, Liu L-Z, Bie M-J, Li C-C, Wu Y-P, Xie X-M, et al. Characterizing the clustered microcalcifications on mammograms to predict the pathological classification and grading: a mathematical modeling approach. J Digital Imaging. 2011;24:764–71.
doi: 10.1007/s10278-011-9381-2
Sickles EA. Breast calcifications: mammographic evaluation. Radiology. 1986;160:289–93.
doi: 10.1148/radiology.160.2.3726103
Eriksson M, Li J, Leifland K, Czene K, Hall P. A comprehensive tool for measuring mammographic density changes over time. Breast Cancer Res. Treat. 2018;169:371–9.
doi: 10.1007/s10549-018-4690-5
Eriksson M, Czene K, Strand F, Zackrisson S, Lindholm P, Lång K, et al. Identification of women at high risk of breast cancer who need supplemental screening. Radiology. 2020;297:327–33.
doi: 10.1148/radiol.2020201620
Rajaram N, Mariapun S, Eriksson M, Tapia J, Kwan PY, Ho WK, et al. Differences in mammographic density between Asian and Caucasian populations: a comparative analysis. Breast Cancer Res. Treat. 2017;161:353–62.
doi: 10.1007/s10549-016-4054-y
Soh WH, Rajaram N, Mariapun S, Eriksson M, Fadzli F, Ho WK, et al. Physical activity and mammographic density in an Asian multi-ethnic cohort. Cancer Causes Control. 2018;29:883–94.
doi: 10.1007/s10552-018-1064-6
Azam S, Eriksson M, Sjölander A, Hellgren R, Gabrielson M, Czene K, et al. Mammographic density change and risk of breast cancer. J. Natl Cancer Inst. 2020;112:391–9.
doi: 10.1093/jnci/djz149
Rauh C, Hack CC, Häberle L, Hein A, Engel A, Schrauder MG, et al. Percent mammographic density and dense area as risk factors for breast cancer. Geburtshilfe Frauenheilkd. 2012;72:727–33.
doi: 10.1055/s-0032-1315129
Barman I, Dingari NC, Saha A, McGee S, Galindo LH, Liu W, et al. Application of Raman spectroscopy to identify microcalcifications and underlying breast lesions at stereotactic core needle biopsy. Cancer Res. 2013;73:3206–15.
doi: 10.1158/0008-5472.CAN-12-2313
D’Orsi CSE, Mendelson EB, Morris EA. Breast imaging reporting and data system:ACR BI-RADS breast imaging atlas. 5th ed. Reston, VA: American College of Radiology; 2013.
Tot T, Gere M, Hofmeyer S, Bauer A, Pellas U. The clinical value of detecting microcalcifications on a mammogram. Seminars Cancer Biol. 2019;72:165–74.
Bui QM, Daniels LB. A review of the role of breast arterial calcification for cardiovascular risk stratification in women. Circulation. 2019;139:1094–101.
doi: 10.1161/CIRCULATIONAHA.118.038092
Rao AA, Feneis J, Lalonde C, Ojeda-Fournier H. A pictorial review of changes in the BI-RADS fifth edition. Radiographics. 2016;36:623–39.
doi: 10.1148/rg.2016150178
Scimeca M, Giannini E, Antonacci C, Pistolese CA, Spagnoli LG, Bonanno E. Microcalcifications in breast cancer: an active phenomenon mediated by epithelial cells with mesenchymal characteristics. BMC Cancer. 2014;14:286.
doi: 10.1186/1471-2407-14-286
Li Q, Jiang Q, Uitto J. Ectopic mineralization disorders of the extracellular matrix of connective tissue: molecular genetics and pathomechanisms of aberrant calcification. Matrix Biol: J Int Soc Matrix Biol. 2014;33:23–8.
doi: 10.1016/j.matbio.2013.06.003
Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomark Prev. 1998;7:1133–44.
Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S. Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst. 2010;102:1224–37.
doi: 10.1093/jnci/djq239
Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res. 2011;13:223.
doi: 10.1186/bcr2942
Santos F, Moreira C, Nóbrega-Pereira S, Bernardes de Jesus B. New insights into the role of epithelial-mesenchymal transition during aging. Int J Mol Sci. 2019;20:891.
doi: 10.3390/ijms20040891